Diabetes and COVID-19 Vaccination / 임상당뇨병
Journal of Korean Diabetes
;
: 221-224, 2021.
Article
in Korean
| WPRIM
| ID: wpr-918906
ABSTRACT
Diabetes is one of the major comorbidities associated with increased risk of mortality and severe clinical outcomes in coronavirus disease 19 (COVID-19) patients. Thus, timely and appropriate vaccination is the most effective strategy for mitigating the risk of COVID-19 infection in people with diabetes. Recent studies have shown that immune response after vaccination is significant in both diabetes and non-diabetes groups, but slightly lower in patients with diabetes. Inadequate glucose control might impair the immune response. Blood glucose monitoring is required more often than usual for several days after vaccination. If a patient’s blood glucose is not controlled adequately, appropriate management should be provided.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Korean
Journal:
Journal of Korean Diabetes
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS